At ILIAS Biologics, they dedicate themselves to the development of paradigm-shifting advances in human medicine. Their platform technology, EXPLOR, makes it possible to load large therapeutic molecules into exosomes, and they are actively developing various therapeutic exosomes, Exo-Targets, as potential treatments for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.

Biotechnology

ILIAS Biologics Inc.

Chulhee Choi

Sungkyu Lee

종희 강

So-Hee Ahn

Seoyeon (Serena) Hyun

Kai Kim

범석 김

Jun Tae Park

Cheol Hyoung Park

Sangchul Kim

The leadership team at ILIAS Biologics Inc. brings a wealth of experience in the pharmaceutical industry, with a focus on Korea and Southeast Asia. They have worked for major companies such as Celgene, Eli Lilly, and CJ CheilJedang, and have a deep understanding of the research and development process. In addition, they hold degrees from top universities in the field, including Pusan National University and The Wharton School. With this combination of experience and education, the team is well-positioned to lead ILIAS Biologics Inc. to success.

Leadership Team

Leadership Team

About

Team members